Keyphrases
Polymorphism
100%
Warfarin
100%
CYP2C9
100%
Warfarin Dose
83%
Genotype
50%
Cytochrome P450 (CYP450)
50%
Cytochrome P450 Polymorphisms
50%
African American
33%
Warfarin Sodium
33%
Warfarin Therapy
33%
Prospective Observational Study
16%
Regression Analysis
16%
Metabolism
16%
Medical Center
16%
Tertiary Care
16%
Clinical Information
16%
Gender Differences
16%
Patient Demographics
16%
Genetic Factors
16%
Dose-response
16%
Metabolic Flexibility
16%
Demographic Information
16%
Surgical Practice
16%
Ethnic Groups
16%
Functional Impact
16%
Warfarin Sensitivity
16%
Inter-patient Variability
16%
Chronic Anticoagulation
16%
CYP2C9 Genotype
16%
Frequency Effect
16%
Backward Stepwise Regression
16%
CYP2C9 Polymorphism
16%
Biochemistry, Genetics and Molecular Biology
CYP2C9
100%
Cytochrome P450
100%
Genotyping
50%
Wild Type
16%
Observational Study
16%
Metabolic Pathway
16%
Dose Response
16%
Genetic Determinism
16%
Scanning Electron Microscopy
16%
Anticoagulation
16%
Sex Difference
16%
CYP2C9*3
16%
Pharmacology, Toxicology and Pharmaceutical Science
Warfarin
100%
CYP2C9
100%
Cytochrome P450
37%
Scanning Electron Microscopy
6%
Observational Study
6%
CYP2C9*3
6%
Neuroscience
Warfarin
100%
Cytochrome P450 2C9
100%
Cytochrome P450
37%
Metabolic Pathway
6%
Scanning Electron Microscopy
6%